539,000 Shares in The Cooper Companies, Inc. (NASDAQ:COO) Bought by Alecta Tjanstepension Omsesidigt

Alecta Tjanstepension Omsesidigt bought a new position in The Cooper Companies, Inc. (NASDAQ:COO) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 539,000 shares of the medical device company’s stock, valued at approximately $49,550,000. Alecta Tjanstepension Omsesidigt owned about 0.27% of Cooper Companies as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of COO. Ashton Thomas Securities LLC bought a new stake in shares of Cooper Companies in the 3rd quarter worth approximately $25,000. Covestor Ltd lifted its stake in Cooper Companies by 144.9% in the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after buying an additional 200 shares during the last quarter. Byrne Asset Management LLC acquired a new position in shares of Cooper Companies during the fourth quarter valued at $33,000. Brown Brothers Harriman & Co. increased its holdings in shares of Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after acquiring an additional 275 shares during the period. Finally, West Financial Advisors LLC bought a new stake in Cooper Companies in the 4th quarter valued at about $49,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Price Performance

Shares of Cooper Companies stock opened at $90.97 on Thursday. The firm has a fifty day moving average price of $92.75 and a two-hundred day moving average price of $99.55. The Cooper Companies, Inc. has a fifty-two week low of $84.76 and a fifty-two week high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company has a market cap of $18.16 billion, a PE ratio of 46.65, a price-to-earnings-growth ratio of 2.25 and a beta of 1.00.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company’s quarterly revenue was up 9.8% on a year-over-year basis. During the same quarter last year, the company earned $0.87 EPS. Analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Citigroup decreased their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Morgan Stanley cut their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, Wells Fargo & Company boosted their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, Cooper Companies presently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.